| RD patients (n = 70) | HD patients (n = 32) | p | |
|---|---|---|---|
| Age (years)* | 64.8 (16.4) | 64.6 (15.1) | 0.940 |
| Male | 55 (78.6) | 24 (75.0) | 0.436 |
| APACHE* | 12.3 (5.9) | 12.6 (5.3) | 0.707 |
| Severe sepsis | 34 (48.6) | 14 (43.8) | 0.153 |
| MDR-GNB infection: Bronchial Pneumonia Urinary tract Bacteriemia Bone/Skin and soft tissue Others | 16 (22.9) 12 (17.1) 11 (15.7) 7 (10.0) 13 (18.6) 11 (15.7) | 7 (21.9) 8 (25.0) 3 (9.4) 5 (12.5) 4 (12.5) 6 (18.8) | 0.838 |
| Baseline GFR (ml/min/1.73 m2)* | 164.3 (117.9) | 147.8 (100.3) | 0.569 |
| CMS dose (mg/kg/day)* | 5.1 (2.0) | 8.5 (3.0) | <0.001 |
| Cminss (mg/L)* | 1.3 (1.1) | 2.1 (1.8) | 0.024 |
| Nephrotoxicity | 11 (15.7) | 15 (46.9) | 0.001 |
| Clinical cure | 57 (81.4) | 22 (68.8) | 0.181 |
| Mortality | 20 (28.6) | 13 (40.6) | 0.227 |
↵* Mean + SD.